CytomX Therapeutics, Inc. (CTMX)
4.88
+0.06
(+1.24%)
USD |
NASDAQ |
Apr 20, 12:45
CytomX Therapeutics SG&A Expense (Quarterly) : 7.36M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 48.23M |
| Rigel Pharmaceuticals, Inc. | 29.99M |
| REGENXBIO, Inc. | 22.38M |
| Ovid Therapeutics, Inc. | 6.422M |
| Olema Pharmaceuticals, Inc. | 6.864M |